⚕ GalenOps CRO console
← SITE004 (DEU)

SITE004-0363

completed
Study: A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer Phase III · Site: SITE004 (DEU) (Dr. Tanaka) · consented 2023-04-29
Adverse events
7
Serious AEs
1
Open data queries
0
Luna dropout signal
–

Adverse events

mild assessed 2026-08-18

Grade 1 Alopecia — outcome: RECOVERED/RESOLVED; onset 2023-06-29 (study day 45); relationship: not assessed

moderate assessed 2026-08-18

Grade 2 Constipation — outcome: RECOVERED/RESOLVED; onset 2024-01-08 (study day 238); relationship: N

moderate assessed 2026-08-18

Grade 2 Anaemia — outcome: RECOVERED/RESOLVED; onset 2024-06-15 (study day 397); relationship: not assessed

mild assessed 2026-08-18

Grade 1 Diarrhoea — outcome: RECOVERED/RESOLVED; onset 2024-07-17 (study day 429); relationship: not assessed

severe serious reported 2026-08-18

Grade 3 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2024-10-12 (study day 516); relationship: not assessed; serious criteria: hospitalization

mild assessed 2026-08-18

Grade 1 Stomatitis — outcome: RECOVERED/RESOLVED; onset 2024-11-29 (study day 564); relationship: not assessed

mild assessed 2026-08-18

Grade 1 Dyspnoea — outcome: RECOVERED/RESOLVED; onset 2025-01-01 (study day 597); relationship: not assessed

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.